Tenax Therapeutics, Inc.

Release Summary

Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., announces first patients enrolled in Levo-CTS Phase 3 clinical study.

Tenax Therapeutics, Inc.